HRT May Increase Risk of Postmenopausal Hearing Loss

Older age at menopause also appears to increase the risk

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

MONDAY, May 15, 2017 (HealthDay News) -- Hearing loss is linked to several factors associated with menopause, according to research published online May 8 in Menopause.

The findings stem from a review of data from 80,972 women in the United States.

According to the investigators, one factor is age at menopause. An older age is tied to a higher risk of hearing loss. A second factor is the use of oral hormone therapy to treat some of the symptoms of menopause. The researchers also found that the longer a woman used hormone therapy, the greater the odds of hearing difficulties.

"The finding from this observational study that women who underwent menopause at a later age and used oral hormone therapy had greater hearing loss was unexpected but should lead to more testing in a randomized, clinical trial," JoAnn Pinkerton, M.D., executive director of the North American Menopause Society, said in a news release from the group. "Information about the potential effect on hearing is important to include in a discussion regarding the risks and benefits of hormone therapy for symptomatic menopausal women."

Abstract/Full Text (subscription or payment may be required)

Last Updated: